Drug Trial Radar · NCT06741969
Nipocalimab in Moderate to Severe Sjogren's Disease
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
655
Actual
Start
Dec 4, 2024
Primary completion
Feb 4, 2027
Study completion May 18, 2029
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Dec 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the clinical efficacy and safety of nipocalimab in participants with moderate to severe Sjogren's disease (SjD).
Conditions
- Sjogrens Syndrome
Interventions
NipocalimabDrug
Nipocalimab SC.
PlaceboDrug
Placebo SC.
Standard of care treatmentDrug
Protocol-defined topical and systemic standard of care background treatments.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in Clinical European League Against Rheumatism Sjogren's Syndrome Disease Activity Index (ClinESSDAI) Score at Week 48Time frame: Baseline to Week 48
Locations
254 sites in 28 countries. Site status is shown where the registry gives one.
Advanced Clinical Research Center
Chula Vista, California
Arthritis & Osteoporosis Medical Center - La Palma
La Palma, California
Providence Medical Foundation
Mission Viejo, California
NovaMed Research
Monterey Park, California
Medvin Clinical Research San Leandro
San Leandro, California
Providence Saint John s Health Center
Santa Monica, California
Solace Clinical Research California
Tustin, California
Inland Rheumatology Clinical Trials Inc.
Upland, California
Denver Arthritis Clinic
Denver, Colorado
Clinical Research of West Florida Inc
Clearwater, Florida
UF Health Rheumatology
Jacksonville, Florida
Suncoast Clinical Research
New Port Richey, Florida
Sarasota Arthritis Center
Sarasota, Florida
BioResearch Partner
South Miami, Florida
Immunology and Rheumatology Research Associates LLC
Suwanee, Georgia
Clinical Investigation Specialists - Clinic of Robert Hozman
Skokie, Illinois
Willow Rheumatology and Wellness PLLC
Willowbrook, Illinois
University of Iowa Hospital and Clinics
Iowa City, Iowa
University of Kansas Medical Center
Kansas City, Kansas
Clinical Research Institute of Michigan, LLC
Saint Clair Shores, Michigan
St. Paul Rheumatology P A
Eagan, Minnesota
AARA Clinical Research- Kansas City Physicians Partners
Kansas City, Missouri
Arthritis Rheumatic And Back Disease Associates
Voorhees Township, New Jersey
NYU Langone Health - Clinical and Translational Science Institute
New York, New York
Pioneer Clinical Research NY
New York, New York
Joint and Muscle Research Institute
Charlotte, North Carolina
Atrium Health SouthPark Rheumatology
Charlotte, North Carolina
Onsite Clinical Solutions
Salisbury, North Carolina
Wright State Physicians Health Center
Fairborn, Ohio
OMRF Rheumatology Center of Excellence
Oklahoma City, Oklahoma
Rheumatology Associates of Oklahoma
Oklahoma City, Oklahoma
Altoona Center For Clinical Research
Duncansville, Pennsylvania
Clinical Research Philadelphia
Philadelphia, Pennsylvania
Low Country Rheumatology PA
Summerville, South Carolina
West Tennessee Research Institute
Jackson, Tennessee
AARA Clinical Research - Murfreesboro Medical Clinic
Murfreesboro, Tennessee
Amarillo Medical Specialists LLP
Amarillo, Texas
Texas Rheumatology Research Institute LLC
Plano, Texas
Fort Bend Rheumatology Associates PLLC
Sugar Land, Texas
Advanced Rheumatology of Houston
The Woodlands, Texas
Showing 40 of 254 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.